Co-Diagnostics Earnings Estimates, EPS & Revenue | NASDAQ:CODX

Comments

Co-Diagnostics Inc Earnings Estimates

CODXNASDAQ

Trade with Public

$1.56

0.106.85%

At close: Apr 17, 5:00 PM EST

$1.55

-0.01-0.64%

After Hours: Apr 17, 7:16 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Co-Diagnostics Earnings Estimates, EPS & Revenue | NASDAQ:CODX

Co-Diagnostics (CODX) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-3.60 and quarterly revenue of $200.00K.

In the most recent quarter (Q4), Co-Diagnostics reported EPS of $-16.65, missing estimates of $-3.90 by 3.27%. Revenue came in at $263.92K, exceeding the estimate of $150.00K by 0.76%.

Over the last 4 quarters, Co-Diagnostics has averaged an EPS surprise of 0.94% and a revenue surprise of 0.65%.

Earnings Date

May 7

EPS Estimate

$-3.600

Quarterly Revenue Estimate

$200.00K

Annual Revenue
(as of Dec 31)

$622.49K

Co-Diagnostics Earnings History

Analyze the earnings history of Co-Diagnostics using advanced sorting and filters.

Loading calendar...

Co-Diagnostics (CODX) Earnings Per Share

The chart below shows Co-Diagnostics's reported EPS compared to analyst estimates over recent quarters.

Co-Diagnostics (CODX) Revenue

The chart below shows Co-Diagnostics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Co-Diagnostics (NASDAQ:CODX) reporting earnings?

Co-Diagnostics (CODX) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on March 31, 2026 for Q4.

What were the latest earnings per share (EPS) for Co-Diagnostics (NASDAQ:CODX)?

The Actual EPS was $-16.65, which missed the estimate of $-3.90.

What were Co-Diagnostics’s (NASDAQ:CODX) revenues?

The Actual Revenue was $263.92K, which beat the estimate of $150.00K.

People Also Watch

Catheter Precision Inc

AMEX:VTAK

$0.88

0.18%

ENDRA Life Sciences Inc

Bluejay Diagnostics Inc

Co-Diagnostics Earnings Estimates, EPS & Revenue | NASDAQ:CODX

Co-Diagnostics (CODX) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-3.60 and quarterly revenue of $200.00K.

In the most recent quarter (Q4), Co-Diagnostics reported EPS of $-16.65, missing estimates of $-3.90 by 3.27%. Revenue came in at $263.92K, exceeding the estimate of $150.00K by 0.76%.

Over the last 4 quarters, Co-Diagnostics has averaged an EPS surprise of 0.94% and a revenue surprise of 0.65%.

Earnings Date

May 7

EPS Estimate

$-3.600

Quarterly Revenue Estimate

$200.00K

Annual Revenue
(as of Dec 31)

$622.49K